Jiangsu Nhwa Pharmaceutical Co., LTD (SHE:002262)
China · Delayed Price · Currency is CNY 23.53
-0.14 (-0.59%)
Aug 14, 2025, 2:45 PM CST
Jiangsu Nhwa Pharmaceutical Co., LTD Company Description
Jiangsu Nhwa Pharmaceutical Co., LTD engages in production, marketing, and services related to central nervous system drugs in China.
It’s product portfolio includes Duloxetine Hcl, Risperidone, Ziprasidone Hcl, Etomidate Fat Emulsion, Gabapentin, Zaleplon, etc.; and Iptakalim, an anti-hypertension drug.
The company’s products are used for treatment of anesthesiology, psychiatry and neurology, as well as APIs.
Jiangsu Nhwa Pharmaceutical Co., LTD was founded in 1978 and is headquartered in Xuzhou, China.
Jiangsu Nhwa Pharmaceutical Co., LTD
| Country | China |
| Founded | 1978 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 5,923 |
| CEO | Jiaquan Sun |
Contact Details
Address: Enhua Technology Building Xuzhou, Jiangsu Province 221004 China | |
| Phone | 86 40 0900 2262 |
| Website | nhwa-group.com |
Stock Details
| Ticker Symbol | 002262 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100000CG8 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jiaquan Sun | GM and Non-Independent Director |
| Gangsheng Li | Chief Financial Officer |
| Qing Fu | Deputy GM and Non-Independent Director |
| Zengliang Chen | Deputy GM and Non-Independent Director |
| Ziliang Yang | Deputy GM and Non-Independent Director |
| Bao Zhou Duan CPA | Deputy GM and Secretary |